Monday, November 30, 2015

MOST AWESOME MOBILE GAME: REVIEWS ON JUNIOR THREE KINGDOMS TRADITIONAL CHINESE VERSION

SHANGHAI, Nov 27 (Bernama-BUSINESS WIRE) -- 少年三國志(Junior Three Kingdoms), a game that unifies elements of card collection, strategy and interaction, recently received quite positive reviews on its Traditional Chinese version.

(Video: https://www.youtube.com/watch?v=EO82Dzok_JE)

“The overall quality of the game is fantastic. The graphics are colorful, making the scenes and hero skills look stunning. The complexity of the game also attracts me, and I have to really study the game to master it. Strategy plays an important role in the different game modes but collecting heroes that work well with each other is the most important thing,” commented the gamer 勇猛赵子龙.

http://mrem.bernama.com/viewsm.php?idm=25826

MOST AWESOME MOBILE GAME: REVIEWS ON JUNIOR THREE KINGDOMS TRADITIONAL CHINESE VERSION

SHANGHAI, Nov 27 (Bernama-BUSINESS WIRE) -- 少年三國志(Junior Three Kingdoms), a game that unifies elements of card collection, strategy and interaction, recently received quite positive reviews on its Traditional Chinese version.

(Video: https://www.youtube.com/watch?v=EO82Dzok_JE)

“The overall quality of the game is fantastic. The graphics are colorful, making the scenes and hero skills look stunning. The complexity of the game also attracts me, and I have to really study the game to master it. Strategy plays an important role in the different game modes but collecting heroes that work well with each other is the most important thing,” commented the gamer 勇猛赵子龙.

http://mrem.bernama.com/viewsm.php?idm=25826

MICF Attractions Include 'Hearme Hearme' Campaign And 'Teddy Bear Hospital Program'

SHAH ALAM, Nov 27 (Bernama) -- The 'HearMe HearMe' Campaign and the 'Teddy Bear Hospital Program' are among the major attractions of the three-day Malaysia Islamic Children's Fair (MICF) which began today at the Shah Alam Convention Centre here.

Managing Director of Zurriyat Ventures Sdn Bhd, who is also MICF chairman, Dayang Lily Maznah Abang Muas said the MICF was a platform for various Islamic-based educational activities, products and services for children.

"For instance the 'HearMe HearMe' campaign is aimed at encouraging children to give their opinions and views on issues, and adults can give their feedback.

"This will help children build confidence to talk, discuss ideas and aspirations with their parents or other adults," she told reporters today.

Lily Maznah said children who visit MICF could participate in activities such as the 'Teddy Bear Hospital Program' managed by the Islamic Medical Association of Malaysia Children and Teens Super Team (IMACAT).

She said under the programme, children could use teddy bears to conduct basic health checks.

"This activity is among the most exciting as the teddy bears will be treated as patients while the children are the parents.

"Through this activity, we will expose the children to eye and tooth issues as well as the importance of nutritious food," she said.

The programme which is in its third year, will also include various competitions aimed at fostering family ties, such as 'Family Treasure Hunt' and 'Family Coloring Contest'.

-- BERNAMA

PFIZER AND ALLERGAN TO COMBINE

NEW YORK & DUBLIN, Nov 30 (Bernama) -- Pfizer Inc. (NYSE:PFE) and Allergan plc (NYSE:AGN) today announced that their boards of directors have unanimously approved, and the companies have entered into, a definitive merger agreement under which Pfizer, a global innovative biopharmaceutical company, will combine with Allergan, a global pharmaceutical company and a leader in a new industry model - Growth Pharma, in a stock transaction currently valued at $363.63 per Allergan share, for a total enterprise value of approximately $160 billion, based on the closing price of Pfizer common stock of $32.18 on November 20, 2015. The transaction represents more than a 30 percent premium based on Pfizer's and Allergan's unaffected share prices as of October 28, 2015. Allergan shareholders will receive 11.3 shares of the combined company for each of their Allergan shares, and Pfizer stockholders will receive one share of the combined company for each of their Pfizer shares.

http://mrem.bernama.com/viewsm.php?idm=25839

Thursday, November 26, 2015

UTI EARNS SECURE TRADE PARTNERSHIP CERTIFICATE FROM SINGAPORE CUSTOMS

LONG BEACH, Calif., Nov 25 (Bernama-GLOBE NEWSWIRE) -- UTi Worldwide Inc. (Nasdaq:UTIW), a global supply chain services and solutions provider, has earned a coveted Secure Trade Partnership (STP) certificate from Singapore Customs. The certificate is awarded to companies that have adopted robust security measures throughout their trading operations to enhance the security of global supply chains and prevent disruptions to the smooth flow of goods.

Among the benefits of receiving the STP certificate are swift trade facilitations (available through Singapore Customs' TradeFIRST bands), automatic "known consignor" designation under the Regulated Cargo Agent Regime, quicker cargo clearance and fewer inspections where STP status is recognized by other national authorities, such as those in China and the US.

http://mrem.bernama.com/viewsm.php?idm=25814

Wednesday, November 25, 2015

Gordagen Positions For Growth And Secures R&D Loan

MELBOURNE, Australia, Nov 25 (Bernama) -- Gordagen Pharmaceuticals, a privately held Australian company commercializing tocotrienol-based nutraceuticals and pharmaceuticals, today outlined the strategic initiatives it is taking in preparation for commercializing its first nutraceutical product in the US early next year.

As part of the Company's long-term growth strategy and shift toward commercial operations with the potential to have multiple marketed products in the coming years, Chairman of the Board, Mr Fred Nadjarian, has announced his retirement from the Board and will assume the role of Special Advisor to the Scientific Advisory Board.

http://mrem.bernama.com/viewsm.php?idm=25813

Tuesday, November 24, 2015

SAMSUNG BIOEPIS RECEIVES POSITIVE CHMP OPINION FOR THE FIRST ETANERCEPT BIOSIMILAR IN THE EUROPEAN UNION

INCHEON, Korea, Nov 23 (Bernama-BUSINESS WIRE) -- Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Benepali® – a biosimilar version of Enbrel® (etanercept), previously known as SB4 – for the treatment of rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis) and plaque psoriasis. This marks the first time the CHMP has adopted a positive opinion on an etanercept biosimilar.